| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −5.7× | −10.3× | |
| Price / Book | 1.0× | 3.2× | |
| Price / Sales | 0.8× | 273.7× | |
| Price / Free cash flow | 5.7× | −25.6× | |
| EV / EBITDA | −36.0× | −20.9× | |
| Earnings yield | −17.6% | −5.2% | |
| Free cash flow yield | 17.7% | −3.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $19.18 | +2.51% | $1.73B | −25.5× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $32.12 | −0.80% | $1.46B | −418.0× | −38.8% | +1266.2% |
CTNAS:CTYCITY THERAPEUTICS INC · 🇺🇸 NAS | $21.85 | −2.46% | $1.1B | −19.3× | 69.1% | — |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.73 | −0.34% | $724.6M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $14.08 | +2.55% | $642.77M | −10.3× | −40.4% |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $13.53 | −2.94% | $430.05M | −7.3× | 46.0% | — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $15.79 | +8.64% | $234.49M | −149.3× | 157.3% | — |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.62 | −4.71% | $12.3M | −0.6× | −560.2% | +150.0% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $2.81 | −1.41% | $2.93M | −0.3× | −65.3% | +95.2% |
